Literature DB >> 2204031

Nucleotide sequence of Clostridium botulinum C1 neurotoxin.

D Hauser1, M W Eklund, H Kurazono, T Binz, H Niemann, D M Gill, P Boquet, M R Popoff.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2204031      PMCID： PMC331989          DOI： 10.1093/nar/18.16.4924

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  3 in total

1.  DNA sequence of exoenzyme C3, an ADP-ribosyltransferase encoded by Clostridium botulinum C and D phages.

Authors:  M Popoff; P Boquet; D M Gill; M W Eklund
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

2.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

3.  Bacteriophage and the toxigenicity of Clostridium botulinum type C.

Authors:  M W Eklund; F T Poysky; S M Reed; C A Smith
Journal:  Science       Date:  1971-04-30       Impact factor: 47.728
  3 in total
  28 in total

1.  Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D.

Authors:  T Binz; H Kurazono; M R Popoff; M W Eklund; G Sakaguchi; S Kozaki; K Krieglstein; A Henschen; D M Gill; H Niemann
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

5.  Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.

Authors:  M Z Atassi; B Z Dolimbek; M Hayakari; J L Middlebrook; B Whitney; M Oshima
Journal:  J Protein Chem       Date:  1996-10

6.  Physicochemical and immunological characterization of the type E botulinum neurotoxin binding protein purified from Clostridium botulinum.

Authors:  B R Singh; J Foley; C Lafontaine
Journal:  J Protein Chem       Date:  1995-01

7.  Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction.

Authors:  E A Szabo; J M Pemberton; P M Desmarchelier
Journal:  Appl Environ Microbiol       Date:  1993-09       Impact factor: 4.792

8.  PCR for detection of Clostridium botulinum type C in avian and environmental samples.

Authors:  G Franciosa; L Fenicia; C Caldiani; P Aureli
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F.

Authors:  K D Campbell; M D Collins; A K East
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Comparative analysis of C3 and botulinal neurotoxin genes and their environment in Clostridium botulinum types C and D.

Authors:  D Hauser; M Gibert; M W Eklund; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.